WPI 2264 (Acitretin 17.5 mg)

Pill imprint WPI 2264 has been identified as Acitretin 17.5 mg.

Acitretin is used in the treatment of psoriasis; psoriatic arthritis; pityriasis rubra pilaris and belongs to the drug class antipsoriatics. Not for use in pregnancy. Acitretin 17.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Professional resources

Related treatment guides

Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.